August 31, 2026
Discovering that you have a brain tumor is understandably overwhelming. When a specialist recommends “watch and wait”—also known as active surveillance—it can at first seem counterintuitive. However, for certain slow-growing, benign, or incidentally discovered brain lesions, active surveillance is often the safest and most effective initial strategy.
“Watch and wait” does not mean ignoring the tumor. Rather, it is a structured monitoring protocol designed to track the lesion over time while avoiding unnecessary surgical risks.
This approach is frequently recommended for specific, asymptomatic, or slow-growing lesions, including:
Every neurosurgical intervention involves weighing potential benefits against operational risks. If a tumor is benign, non-progressive, and causing no neurological deficits, immediate surgery may introduce risks—such as tissue disruption or recovery complications—without offering immediate health advantages.
When choosing active surveillance, neurosurgeons prioritize preserving long-term neurological function and overall quality of life.
An active surveillance protocol includes structured diagnostic follow-up:
If follow-up scans reveal tumor growth or if symptoms develop, your neurosurgeon will discuss transitioning from active surveillance to active treatment, such as surgical resection or radio-interventional management.